Skip to main content

Advertisement

Table 1 Patient baseline characteristics

From: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

  Losartan (n = 20) Telmisartan (n = 20) P value
Mean ± SD age (years) 56.2 ± 11.0 55.3 ± 12.4 NS
Males/females 11/9 12/8  
Office blood pressure (mmHg)    
   Mean ± SD SBP 149.7 ± 9.0 151.3 ± 7.1  
   Mean ± SD DBP 91.2 ± 7.4 89.8 ± 8.7  
24-hour mean blood pressure (mmHg)    
   Mean ± SD SBP 142.8 ± 12.0 143.6 ± 14.0 NS
   Mean ± SD DBP 88.8 ± 10.2 88.3 ± 9.5 NS
Mean ± SD body mass index (kg/m2) 32.1 ± 7.2 34.5 ± 6.3 NS
Impaired glucose tolerance (n) 19 17 NS
Type 2 diabetics (n) 1 3 NS
Metabolic syndrome components (n)a    
   3 11 10 NS
   4 7 8 NS
   5 2 2 NS
Total cholesterol (mg/dl) 212.6 ± 45.8 209.6 ± 50.8 NS
Low-density lipoprotein cholesterol (mg/dl) 134 ± 44 138 ± 34 NS
High-density lipoprotein cholesterol (mg/dl) 51.2 ± 11 56.3 ± 17 NS
Triglycerides (mg/dl) 221 ± 32 210 ± 23 NS
  1. a Based on World Health Organization criteria [1].